NATIVE GENE THERAPY Trademark

Trademark Overview

On Monday, March 27, 2017, a trademark application was filed for NATIVE GENE THERAPY with the United States Patent and Trademark Office. The USPTO has given the NATIVE GENE THERAPY trademark a serial number of 87387194. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 22, 2021. This trademark is owned by VL42, Inc.. The NATIVE GENE THERAPY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease
native gene therapy

General Information

Serial Number87387194
Word MarkNATIVE GENE THERAPY
Filing DateMonday, March 27, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Disclaimer with Predetermined Text"GENE THERAPY"
Goods and ServicesPharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 31, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOMEGA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameVL42, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameVL42, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, November 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, April 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 29, 2021EXTENSION 5 GRANTED
Thursday, April 15, 2021EXTENSION 5 FILED
Thursday, April 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 15, 2021TEAS EXTENSION RECEIVED
Thursday, February 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 14, 2020EXTENSION 4 GRANTED
Wednesday, October 14, 2020EXTENSION 4 FILED
Wednesday, October 14, 2020TEAS EXTENSION RECEIVED
Thursday, April 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 14, 2020EXTENSION 3 GRANTED
Tuesday, April 14, 2020EXTENSION 3 FILED
Tuesday, April 14, 2020TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019EXTENSION 2 GRANTED
Wednesday, October 16, 2019EXTENSION 2 FILED
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Thursday, April 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2019EXTENSION 1 GRANTED
Tuesday, April 16, 2019EXTENSION 1 FILED
Tuesday, April 16, 2019TEAS EXTENSION RECEIVED
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 12, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2018SUSPENSION LETTER WRITTEN
Monday, January 8, 2018ASSIGNED TO EXAMINER
Friday, January 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 4, 2018ASSIGNED TO LIE
Wednesday, December 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 27, 2017ASSIGNED TO EXAMINER
Monday, June 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2017NON-FINAL ACTION E-MAILED
Monday, June 26, 2017NON-FINAL ACTION WRITTEN
Monday, June 19, 2017ASSIGNED TO EXAMINER
Friday, March 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

therapy gene native disease diseases channelopathies hepatic bone haploinsufficiencies endocrine cardiovascular skeletal renal